AI slashes pharma R&D time and cost
The speakers argued that AI partnerships, like Novo Nordisk with OpenAI and Novartis with Anthropic, will dramatically cut drug development timelines and costs, improving pharmaceutical company fundamentals.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.